GB201513442D0 - Transdermal patch - Google Patents

Transdermal patch

Info

Publication number
GB201513442D0
GB201513442D0 GBGB1513442.2A GB201513442A GB201513442D0 GB 201513442 D0 GB201513442 D0 GB 201513442D0 GB 201513442 A GB201513442 A GB 201513442A GB 201513442 D0 GB201513442 D0 GB 201513442D0
Authority
GB
United Kingdom
Prior art keywords
transdermal patch
transdermal
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1513442.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to GBGB1513442.2A priority Critical patent/GB201513442D0/en
Publication of GB201513442D0 publication Critical patent/GB201513442D0/en
Priority to KR1020187005892A priority patent/KR20180031039A/ko
Priority to MX2018001320A priority patent/MX2018001320A/es
Priority to MA042522A priority patent/MA42522A/fr
Priority to BR112018001564A priority patent/BR112018001564A2/pt
Priority to PCT/GB2016/052308 priority patent/WO2017017453A1/en
Priority to SG10201913253TA priority patent/SG10201913253TA/en
Priority to EP16747573.0A priority patent/EP3328432A1/en
Priority to JP2018504675A priority patent/JP6793718B2/ja
Priority to AU2016298762A priority patent/AU2016298762A1/en
Priority to CN201680055303.0A priority patent/CN108136028A/zh
Priority to US15/748,545 priority patent/US20180221298A1/en
Priority to CA2994109A priority patent/CA2994109A1/en
Priority to ARP160102319A priority patent/AR105534A1/es
Priority to TW105124075A priority patent/TW201707693A/zh
Priority to IL256994A priority patent/IL256994A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1513442.2A 2015-07-30 2015-07-30 Transdermal patch Ceased GB201513442D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1513442.2A GB201513442D0 (en) 2015-07-30 2015-07-30 Transdermal patch
CA2994109A CA2994109A1 (en) 2015-07-30 2016-07-28 Transdermal delivery system
SG10201913253TA SG10201913253TA (en) 2015-07-30 2016-07-28 Transdermal delivery system
JP2018504675A JP6793718B2 (ja) 2015-07-30 2016-07-28 経皮送達系
MA042522A MA42522A (fr) 2015-07-30 2016-07-28 Système d'administration transdermique
BR112018001564A BR112018001564A2 (pt) 2015-07-30 2016-07-28 sistema de entrega transdérmica
PCT/GB2016/052308 WO2017017453A1 (en) 2015-07-30 2016-07-28 Transdermal delivery system
KR1020187005892A KR20180031039A (ko) 2015-07-30 2016-07-28 경피 전달 시스템
EP16747573.0A EP3328432A1 (en) 2015-07-30 2016-07-28 Transdermal delivery system
MX2018001320A MX2018001320A (es) 2015-07-30 2016-07-28 Sistema de administracion transdermica.
AU2016298762A AU2016298762A1 (en) 2015-07-30 2016-07-28 Transdermal delivery system
CN201680055303.0A CN108136028A (zh) 2015-07-30 2016-07-28 经皮递送系统
US15/748,545 US20180221298A1 (en) 2015-07-30 2016-07-28 Transdermal delivery system
TW105124075A TW201707693A (zh) 2015-07-30 2016-07-29 經皮傳遞系統
ARP160102319A AR105534A1 (es) 2015-07-30 2016-07-29 Sistema de suministro transdérmico
IL256994A IL256994A (en) 2015-07-30 2018-01-18 Transdermal delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1513442.2A GB201513442D0 (en) 2015-07-30 2015-07-30 Transdermal patch

Publications (1)

Publication Number Publication Date
GB201513442D0 true GB201513442D0 (en) 2015-09-16

Family

ID=54062903

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1513442.2A Ceased GB201513442D0 (en) 2015-07-30 2015-07-30 Transdermal patch

Country Status (16)

Country Link
US (1) US20180221298A1 (https=)
EP (1) EP3328432A1 (https=)
JP (1) JP6793718B2 (https=)
KR (1) KR20180031039A (https=)
CN (1) CN108136028A (https=)
AR (1) AR105534A1 (https=)
AU (1) AU2016298762A1 (https=)
BR (1) BR112018001564A2 (https=)
CA (1) CA2994109A1 (https=)
GB (1) GB201513442D0 (https=)
IL (1) IL256994A (https=)
MA (1) MA42522A (https=)
MX (1) MX2018001320A (https=)
SG (1) SG10201913253TA (https=)
TW (1) TW201707693A (https=)
WO (1) WO2017017453A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
CN1780611B (zh) * 2003-04-30 2013-01-30 珀杜医药公司 包括活性剂部分以及在活性剂层远侧的逆转剂的抗改造透皮剂型
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
DE102005011517A1 (de) * 2005-03-10 2006-09-21 Grünenthal GmbH Transdermales therapeutisches System zur Verabreichung von Analgetika
TWI541246B (zh) * 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
GB201309654D0 (en) * 2013-05-30 2013-07-17 Euro Celtique Sa Method

Also Published As

Publication number Publication date
JP2018528176A (ja) 2018-09-27
MA42522A (fr) 2018-06-06
MX2018001320A (es) 2018-08-15
SG10201913253TA (en) 2020-03-30
JP6793718B2 (ja) 2020-12-02
KR20180031039A (ko) 2018-03-27
TW201707693A (zh) 2017-03-01
BR112018001564A2 (pt) 2018-09-18
EP3328432A1 (en) 2018-06-06
WO2017017453A1 (en) 2017-02-02
US20180221298A1 (en) 2018-08-09
AR105534A1 (es) 2017-10-11
CN108136028A (zh) 2018-06-08
AU2016298762A1 (en) 2018-02-15
CA2994109A1 (en) 2017-02-02
IL256994A (en) 2018-03-29

Similar Documents

Publication Publication Date Title
ZA201803213B (en) A health-monitor patch
IL252550A0 (en) Cannabinoid compounds through the skin
GB201517222D0 (en) Patch antenna
IL248984A0 (en) Transdermal cream
GB201413018D0 (en) Beyond 1A
IL250943A0 (en) Opiformol patch
GB201600920D0 (en) Transdermal patch
GB2535614B (en) A skin patch
IL252062A0 (en) Transdermal compositions
PT3191170T (pt) Adesivo capaz de produzir microcorrentes
AU366120S (en) Footwear
GB2532452B (en) Preventing browser-originating attacks
GB201507909D0 (en) Footwear
GB201520647D0 (en) Transdermal patches
GB201416336D0 (en) Bonding patch
PL3612182T3 (pl) Plaster zawierający rupatadynę
EP3150205A4 (en) Transdermal preparation
GB201408867D0 (en) Sole
TWM533991U (en) Skin patch
GB201513442D0 (en) Transdermal patch
GB201600919D0 (en) Transdermal patch
GB201600918D0 (en) Transdermal patch
GB201513443D0 (en) Patch
GB201505956D0 (en) Patches
GB201502403D0 (en) Patches

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)